Roche (Werner Helicase Inhibitor Rights) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Roche (Werner Helicase Inhibitor Rights) General Information

Description

Development rights of research and potential therapeutic drug to explore new treatment pathways for certain cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Basel
  • Switzerland
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche (Werner Helicase Inhibitor Rights) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche (Werner Helicase Inhibitor Rights)‘s full profile, request access.

Request a free trial

Roche (Werner Helicase Inhibitor Rights) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche (Werner Helicase Inhibitor Rights)‘s full profile, request access.

Request a free trial

Roche (Werner Helicase Inhibitor Rights) FAQs

  • Where is Roche (Werner Helicase Inhibitor Rights) headquartered?

    Roche (Werner Helicase Inhibitor Rights) is headquartered in Basel, Switzerland.

  • What industry is Roche (Werner Helicase Inhibitor Rights) in?

    Roche (Werner Helicase Inhibitor Rights)’s primary industry is Buildings and Property.

  • Is Roche (Werner Helicase Inhibitor Rights) a private or public company?

    Roche (Werner Helicase Inhibitor Rights) is a Private company.

  • What is Roche (Werner Helicase Inhibitor Rights)’s current revenue?

    The current revenue for Roche (Werner Helicase Inhibitor Rights) is .

  • Who are Roche (Werner Helicase Inhibitor Rights)’s investors?

    Roche has invested in Roche (Werner Helicase Inhibitor Rights).

  • When was Roche (Werner Helicase Inhibitor Rights) acquired?

    Roche (Werner Helicase Inhibitor Rights) was acquired on 04-Jun-2025.

  • Who acquired Roche (Werner Helicase Inhibitor Rights)?

    Roche (Werner Helicase Inhibitor Rights) was acquired by Vividion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process